Table 4.
—Characteristics of Sarcoidosis Cases Based on Data From Participant Supplemental Surveys
| All With Supplemental Survey (N = 691) |
||
| Survey Item | No. | % |
| Symptoms at diagnosis | ||
| Shortness of breath | 309 | 45 |
| Cough | 275 | 40 |
| Nasal/sinus congestion | 173 | 25 |
| Chest pain | 152 | 22 |
| Numbness/tingling (arms, legs, face) | 99 | 14 |
| Muscle pain | 200 | 29 |
| Fatigue | 281 | 41 |
| Palpitations | 99 | 14 |
| Headaches | 114 | 17 |
| Othera | 87 | 13 |
| Medications | ||
| Prednisone | 485 | 70 |
| Methotrexate | 61 | 9 |
| Plaquenil | 54 | 8 |
| Inhaled corticosteroids | 202 | 29 |
| Nasal corticosteroids | 209 | 30 |
| Otherb | 108 | 16 |
| Family history of sarcoidosis | ||
| Primary relative | 93 | 14 |
| Any relative | 195 | 28 |
a
Other symptoms reported: skin rash (including erythema nodosum), unintentional weight loss, eye problems.
b
Other reported medications include topical corticosteroid creams, corticosteroid eye drops.